{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T04:27:09Z","timestamp":1789878429904,"version":"4.0.1"},"reference-count":45,"publisher":"American Association for Cancer Research (AACR)","issue":"5","license":[{"start":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T00:00:00Z","timestamp":1779840000000},"content-version":"vor","delay-in-days":26,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["R15CA242057"],"award-info":[{"award-number":["R15CA242057"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["T32CA186895"],"award-info":[{"award-number":["T32CA186895"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["R21AI173784"],"award-info":[{"award-number":["R21AI173784"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["P30ACA033572"],"award-info":[{"award-number":["P30ACA033572"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000057","name":"National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["P20 GM130448"],"award-info":[{"award-number":["P20 GM130448"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000057","name":"National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["P20 GM103418"],"award-info":[{"award-number":["P20 GM103418"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000057","name":"National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["R35 GM140852"],"award-info":[{"award-number":["R35 GM140852"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["aacrjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,5,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title\/>\n                    <jats:p>Cervical cancers remain a significant health burden. Limitations on cervical cancer chemotherapeutic intervention caused by toxic side effects are a persistent barrier to care. In this study, we show that the human papillomavirus oncogenes that cause most cervical cancers also increase the levels of a cancer-associated isoform of proliferating cell nuclear antigen (PCNA) known as caPCNA. The abundance of caPCNA is specifically elevated in cervical cancer. Similar to observations in other cancers, we found that a small-molecule inhibitor of caPCNA (AOH1996) selectively killed cell line, organoid, and xenograft models of cervical cancer. Our subsequent molecular analysis identified a novel ability of AOH1996 to induce cell death by disrupting the interaction between PCNA and \u03b3-tubulin, resulting in mitotic arrest. We show AOH1996 selectively induces mitotic death in transformed cells, because these cells attempt to progress through mitosis, rather than decondensing their chromosomes and reforming their nuclear membranes like untransformed control cells. Furthermore, we show that these differences allow AOH1996 to specifically sensitize cervical cancer cells to cisplatin, a frontline chemotherapeutic used to treat cervical cancer. We found that subtherapeutic doses of AOH1996 and cisplatin could reduce cervical cancer xenograft growth and improve survival, similarly to a therapeutic dose of cisplatin without the cisplatin-induced toxicity that restricts care. To our knowledge, this study provides the first evidence that AOH1996 can function as a cisplatin-sensitizing agent in cervical cancer models.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Significance:<\/jats:title>\n                    <jats:p>We identify a novel mechanism by which the small-molecule inhibitor AOH1996 targets cancer-associated PCNA to induce mitotic death in cervical cancer cells. By disrupting PCNA:\u03b3-tubulin interactions, AOH1996 selectively sensitizes tumors to a lower dose of cisplatin, enabling effective therapy with reduced toxicity and suggesting a potential strategy to reduce treatment-associated toxicity.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1158\/2767-9764.crc-25-0648","type":"journal-article","created":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T21:53:57Z","timestamp":1777326837000},"page":"1220-1238","update-policy":"https:\/\/doi.org\/10.1158\/crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Targeting Cancer-Associated PCNA with AOH1996 Induces Mitotic Catastrophe and Enhances Cisplatin Therapy in Cervical Cancer"],"prefix":"10.1158","volume":"6","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5515-0968","authenticated-orcid":false,"given":"Sebastian O.","family":"Wendel","sequence":"first","affiliation":[{"id":[{"id":"https:\/\/ror.org\/05p1j8758","id-type":"ROR","asserted-by":"publisher"}],"name":"Kansas State University 1 College of Health and Human Science, , Manhattan, Kansas."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-4027-8143","authenticated-orcid":false,"given":"Grant M.","family":"Brooke","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/05p1j8758","id-type":"ROR","asserted-by":"publisher"}],"name":"Kansas State University 2 Division of Biology, , Manhattan, Kansas."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4407-7144","authenticated-orcid":false,"given":"Changkun","family":"Hu","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/007ps6h72","id-type":"ROR","asserted-by":"publisher"}],"name":"Fred Hutchinson Cancer Center 3 Basic Sciences Division, Howard Hughes Medical Institute, , Seattle, Washington."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-2584-8684","authenticated-orcid":false,"given":"Allison R.","family":"Sandoval","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/05p1j8758","id-type":"ROR","asserted-by":"publisher"}],"name":"Kansas State University 2 Division of Biology, , Manhattan, Kansas."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0181-8958","authenticated-orcid":false,"given":"Pouya","family":"Haratipour","sequence":"additional","affiliation":[{"name":"4Department of Cancer Biology and Molecular Medicine, Beckman Research Institute of City of Hope, Duarte, California."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3536-5056","authenticated-orcid":false,"given":"Long","family":"Gu","sequence":"additional","affiliation":[{"name":"5Department of Molecular Diagnostics and Experimental Therapeutics, Beckman Research Institute of City of Hope, Duarte, California."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5857-2851","authenticated-orcid":false,"given":"Malaney","family":"Young","sequence":"additional","affiliation":[{"name":"5Department of Molecular Diagnostics and Experimental Therapeutics, Beckman Research Institute of City of Hope, Duarte, California."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-7153-3802","authenticated-orcid":false,"given":"Maryam","family":"Zangi","sequence":"additional","affiliation":[{"name":"4Department of Cancer Biology and Molecular Medicine, Beckman Research Institute of City of Hope, Duarte, California."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6599-4443","authenticated-orcid":false,"given":"Brittany L.","family":"Rasche","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/05p1j8758","id-type":"ROR","asserted-by":"publisher"}],"name":"Kansas State University 6 College of Veterinary Medicine, , Manhattan, Kansas."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9180-0323","authenticated-orcid":false,"given":"N.S.","family":"Banerjee","sequence":"additional","affiliation":[{"name":"7Department of Biochemistry and Molecular Genetics, Heersink School of Medicine, Birmingham, Alabama."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3537-9850","authenticated-orcid":false,"given":"Jennifer","family":"Jossart","sequence":"additional","affiliation":[{"name":"5Department of Molecular Diagnostics and Experimental Therapeutics, Beckman Research Institute of City of Hope, Duarte, California."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-5628-5599","authenticated-orcid":false,"given":"Kelly","family":"Garvin","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/03k1gpj17","id-type":"ROR","asserted-by":"publisher"}],"name":"Colorado State University 8 Department of Clinical Sciences, , Fort Collins, Colorado."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1775-0727","authenticated-orcid":false,"given":"Brian V.","family":"Geisbrecht","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/05p1j8758","id-type":"ROR","asserted-by":"publisher"}],"name":"Kansas State University 9 Department of Biochemistry and Molecular Biophysics, , Manhattan, Kansas."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1627-2396","authenticated-orcid":false,"given":"Rachel","family":"Cianciolo","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/00rs6vg23","id-type":"ROR","asserted-by":"publisher"}],"name":"Ohio State University 10 Department of Veterinary Biosciences, College of Veterinary Medicine, , Columbus, Ohio."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2993-5179","authenticated-orcid":false,"given":"Jacob","family":"Cawley","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/03k1gpj17","id-type":"ROR","asserted-by":"publisher"}],"name":"Colorado State University 8 Department of Clinical Sciences, , Fort Collins, Colorado."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9889-3502","authenticated-orcid":false,"given":"J. Jefferson P.","family":"Perry","sequence":"additional","affiliation":[{"name":"5Department of Molecular Diagnostics and Experimental Therapeutics, Beckman Research Institute of City of Hope, Duarte, California."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5099-8137","authenticated-orcid":false,"given":"Robert J.","family":"Hickey","sequence":"additional","affiliation":[{"name":"4Department of Cancer Biology and Molecular Medicine, Beckman Research Institute of City of Hope, Duarte, California."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7624-8510","authenticated-orcid":false,"given":"Linda H.","family":"Malkas","sequence":"additional","affiliation":[{"name":"5Department of Molecular Diagnostics and Experimental Therapeutics, Beckman Research Institute of City of Hope, Duarte, California."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3971-716X","authenticated-orcid":false,"given":"Nicholas A.","family":"Wallace","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/05p1j8758","id-type":"ROR","asserted-by":"publisher"}],"name":"Kansas State University 11 HHS Deans Office, , Manhattan, Kansas."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1086","published-online":{"date-parts":[[2026,5,27]]},"reference":[{"key":"2026052706014662800_bib1","first-page":"209","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"2026052706014662800_bib2","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1042\/CS20050369","article-title":"Molecular biology of human papillomavirus infection and cervical cancer","volume":"110","author":"Doorbar","year":"2006","journal-title":"Clin Sci (Lond)"},{"key":"2026052706014662800_bib3","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1038\/nrc2886","article-title":"Human papillomavirus oncoproteins: pathways to transformation","volume":"10","author":"Moody","year":"2010","journal-title":"Nat Rev Cancer"},{"key":"2026052706014662800_bib4","doi-asserted-by":"crossref","first-page":"e191","DOI":"10.1016\/S2214-109X(19)30482-6","article-title":"Estimates of incidence and mortality of cervical cancer in 2018: a worldwide analysis","volume":"8","author":"Arbyn","year":"2020","journal-title":"Lancet Glob Health"},{"key":"2026052706014662800_bib5","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S0140-6736(18)32470-X","article-title":"Cervical cancer","volume":"393","author":"Cohen","year":"2019","journal-title":"Lancet"},{"key":"2026052706014662800_bib6","doi-asserted-by":"crossref","first-page":"5802","DOI":"10.1200\/JCO.2008.16.4368","article-title":"Reducing uncertainties about the effects of chemoradiotherapy for cervical cancer: a systematic review and meta-analysis of individual patient data from 18 randomized trials","volume":"26","author":"Chemoradiotherapy for Cervical Cancer Meta-Analysis Collaboration","year":"2008","journal-title":"J Clin Oncol"},{"key":"2026052706014662800_bib7","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.3390\/cancers3011351","article-title":"Cisplatin as an anti-tumor drug: cellular mechanisms of activity, drug resistance and induced side effects","volume":"3","author":"Florea","year":"2011","journal-title":"Cancers"},{"key":"2026052706014662800_bib8","doi-asserted-by":"crossref","first-page":"201367","DOI":"10.4061\/2010\/201367","article-title":"Cellular responses to cisplatin-induced DNA damage","volume":"2010","author":"Basu","year":"2010","journal-title":"J Nucleic Acids"},{"key":"2026052706014662800_bib9","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.toxlet.2015.06.012","article-title":"An integrated view of cisplatin-induced nephrotoxicity and ototoxicity","volume":"237","author":"Karasawa","year":"2015","journal-title":"Toxicol Lett"},{"key":"2026052706014662800_bib10","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.clon.2016.10.002","article-title":"The impact of systemic therapy beyond first-line treatment for advanced cervical cancer","volume":"29","author":"McLachlan","year":"2017","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"2026052706014662800_bib11","doi-asserted-by":"crossref","first-page":"28","DOI":"10.3390\/cancers13010028","article-title":"High risk \u03b1-HPV E6 impairs translesion synthesis by blocking POL\u03b7 induction","volume":"13","author":"Wendel","year":"2020","journal-title":"Cancers (Basel)"},{"key":"2026052706014662800_bib12","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1186\/s12985-022-01899-8","article-title":"HPV 16 E7 alters translesion synthesis signaling","volume":"19","author":"Wendel","year":"2022","journal-title":"Virol J"},{"key":"2026052706014662800_bib13","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.virol.2020.07.004","article-title":"DNA repair gene expression is increased in HPV positive head and neck squamous cell carcinomas","volume":"548","author":"Holcomb","year":"2020","journal-title":"Virology"},{"key":"2026052706014662800_bib14","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.radonc.2016.02.009","article-title":"Relationships between P53 mutation, HPV status and outcome in oropharyngeal squamous cell carcinoma","volume":"118","author":"Hong","year":"2016","journal-title":"Radiother Oncol"},{"key":"2026052706014662800_bib15","doi-asserted-by":"crossref","first-page":"779042","DOI":"10.3389\/fonc.2021.779042","article-title":"PCNA in cervical intraepithelial neoplasia and cervical cancer: an interaction network analysis of differentially expressed genes","volume":"11","author":"Giannos","year":"2021","journal-title":"Front Oncol"},{"key":"2026052706014662800_bib16","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/j.cell.2007.05.003","article-title":"PCNA, the maestro of the replication fork","volume":"129","author":"Moldovan","year":"2007","journal-title":"Cell"},{"key":"2026052706014662800_bib17","doi-asserted-by":"crossref","first-page":"2058","DOI":"10.1021\/acs.jmedchem.4c00526","article-title":"Targeting the \u201cundruggable\u201d: small-molecule inhibitors of proliferating cell nuclear antigen (PCNA) in the spotlight in cancer therapy","volume":"68","author":"Wang","year":"2025","journal-title":"J Med Chem"},{"key":"2026052706014662800_bib18","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/j.tig.2024.02.006","article-title":"PCNA cycling dynamics during DNA replication and repair in mammals","volume":"40","author":"Kang","year":"2024","journal-title":"Trends Genet"},{"key":"2026052706014662800_bib19","first-page":"7","article-title":"Proliferating cell nuclear antigen: a novel growth and therapeutic biomarker","volume":"22","author":"Gera","year":"2024","journal-title":"Clin Transl Metab"},{"key":"2026052706014662800_bib20","doi-asserted-by":"crossref","first-page":"14289","DOI":"10.1074\/jbc.M112.353201","article-title":"Identification of small molecule proliferating cell nuclear antigen (PCNA) inhibitor that disrupts interactions with PIP-box proteins and inhibits DNA replication","volume":"287","author":"Punchihewa","year":"2012","journal-title":"J Biol Chem"},{"key":"2026052706014662800_bib21","doi-asserted-by":"crossref","first-page":"e0223894","DOI":"10.1371\/journal.pone.0223894","article-title":"Additive effects of a small molecular PCNA inhibitor PCNA-I1S and DNA damaging agents on growth inhibition and DNA damage in prostate and lung cancer cells","volume":"14","author":"Lu","year":"2019","journal-title":"PLoS One"},{"key":"2026052706014662800_bib22","doi-asserted-by":"crossref","first-page":"4808","DOI":"10.1002\/pmic.200600142","article-title":"The discovery of labile methyl esters on proliferating cell nuclear antigen by MS\/MS","volume":"6","author":"Hoelz","year":"2006","journal-title":"Proteomics"},{"key":"2026052706014662800_bib23","doi-asserted-by":"crossref","first-page":"6053","DOI":"10.1158\/1078-0432.CCR-18-0592","article-title":"The anti-cancer activity of a first-in-class small molecule targeting PCNA","volume":"24","author":"Gu","year":"2018","journal-title":"Clin Cancer Res"},{"key":"2026052706014662800_bib24","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1016\/j.chembiol.2023.07.001","article-title":"Small molecule targeting of transcription-replication conflict for selective chemotherapy","volume":"30","author":"Gu","year":"2023","journal-title":"Cell Chem Biol"},{"key":"2026052706014662800_bib25","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1186\/s40164-024-00586-4","article-title":"AOH1996 targets mitochondrial dynamics and metabolism in leukemic stem cells via mitochondrial PCNA inhibition","volume":"13","author":"Kang","year":"2024","journal-title":"Exp Hematol Oncol"},{"key":"2026052706014662800_bib26","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1053\/j.gastro.2025.02.038","article-title":"Therapeutic targeting of oncogene-induced transcription-replication conflicts in pancreatic ductal adenocarcinoma","volume":"169","author":"Smith","year":"2025","journal-title":"Gastroenterology"},{"key":"2026052706014662800_bib27","doi-asserted-by":"crossref","first-page":"3705","DOI":"10.4049\/jimmunol.1601932","article-title":"Identification of C3b-binding small molecule complement inhibitors using cheminformatics","volume":"198","author":"Garcia","year":"2017","journal-title":"J Immunol"},{"key":"2026052706014662800_bib28","doi-asserted-by":"crossref","first-page":"9441","DOI":"10.1093\/nar\/gkx619","article-title":"Phosphorylation regulates human pol\u03b7 stability and damage bypass throughout the cell cycle","volume":"45","author":"Bertoletti","year":"2017","journal-title":"Nucleic Acids Res"},{"key":"2026052706014662800_bib29","doi-asserted-by":"crossref","first-page":"W739","DOI":"10.1093\/nar\/gkac382","article-title":"SynergyFinder 3.0: an interactive analysis and consensus interpretation of multi-drug synergies across multiple samples","volume":"50","author":"Ianevski","year":"2022","journal-title":"Nucleic Acids Res"},{"key":"2026052706014662800_bib30","doi-asserted-by":"crossref","first-page":"4862","DOI":"10.1128\/JVI.01202-07","article-title":"Casein kinase II motif-dependent phosphorylation of human papillomavirus E7 protein promotes P130 degradation and S-phase induction in differentiated human keratinocytes","volume":"82","author":"Genovese","year":"2008","journal-title":"J Virol"},{"key":"2026052706014662800_bib31","doi-asserted-by":"crossref","first-page":"e02184","DOI":"10.1128\/JVI.02184-19","article-title":"Beta human papillomavirus 8E6 attenuates LATS phosphorylation after failed cytokinesis","volume":"94","author":"Dacus","year":"2020","journal-title":"J Virol"},{"key":"2026052706014662800_bib32","first-page":"e50203","article-title":"Chromosome preparation from cultured cells","author":"Howe","year":"2014","journal-title":"J Vis Exp"},{"key":"2026052706014662800_bib33","first-page":"57653","article-title":"Characterizing DNA repair processes at transient and long-lasting double-strand DNA breaks by immunofluorescence microscopy","author":"Murthy","year":"2018","journal-title":"J Vis Exp"},{"issue":"Suppl 5","key":"2026052706014662800_bib34","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1186\/s12920-019-0514-7","article-title":"GENT2: an updated gene expression database for normal and tumor tissues","volume":"12","author":"Park","year":"2019","journal-title":"BMC Med Genomics"},{"key":"2026052706014662800_bib35","article-title":"Expression of PCNA in cervical cancer","author":"The Human Protein Atlas","year":"2024"},{"key":"2026052706014662800_bib36","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1038\/s42003-021-02280-1","article-title":"The \u03b3-tubulin meshwork assists in the recruitment of PCNA to chromatin in mammalian cells","volume":"4","author":"Corvaisier","year":"2021","journal-title":"Commun Biol"},{"key":"2026052706014662800_bib37","first-page":"M81","article-title":"Centrosome abnormalities, genomic instability and carcinogenic progression","volume":"1471","author":"Duensing","year":"2001","journal-title":"Biochim Biophys Acta"},{"key":"2026052706014662800_bib38","doi-asserted-by":"crossref","first-page":"1952","DOI":"10.1080\/15384101.2020.1785724","article-title":"ATAD5 suppresses centrosome over-duplication by regulating UAF1 and ID1","volume":"19","author":"Kim","year":"2020","journal-title":"Cell Cycle"},{"key":"2026052706014662800_bib39","doi-asserted-by":"crossref","first-page":"2951","DOI":"10.4161\/cc.8.18.9539","article-title":"DNA damage-induced cell death is enhanced by progression through mitosis","volume":"8","author":"Varmark","year":"2009","journal-title":"Cell Cycle"},{"key":"2026052706014662800_bib40","doi-asserted-by":"crossref","first-page":"55","DOI":"10.5049\/EBP.2014.12.2.55","article-title":"Cisplatin-induced kidney dysfunction and perspectives on improving treatment strategies","volume":"12","author":"Oh","year":"2014","journal-title":"Electrolyte Blood Press"},{"key":"2026052706014662800_bib41","doi-asserted-by":"crossref","first-page":"216","DOI":"10.5483\/BMBRep.2023-0025","article-title":"Expanding roles of centrosome abnormalities in cancers","volume":"56","author":"Song","year":"2023","journal-title":"BMB Rep"},{"key":"2026052706014662800_bib42","doi-asserted-by":"crossref","first-page":"4560","DOI":"10.1158\/0008-5472.CAN-21-0399","article-title":"Development of a novel mouse model of spontaneous high-risk HPVE6\/E7-expressing carcinoma in the cervicovaginal tract","volume":"81","author":"Henkle","year":"2021","journal-title":"Cancer Res"},{"key":"2026052706014662800_bib43","doi-asserted-by":"crossref","first-page":"200759","DOI":"10.1016\/j.omton.2024.200759","article-title":"Targeting MELK improves PD-1 blockade efficiency in cervical cancer via enhancing antitumor immunity","volume":"32","author":"Wang","year":"2024","journal-title":"Mol Ther Oncol"},{"key":"2026052706014662800_bib44","doi-asserted-by":"crossref","first-page":"2447403","DOI":"10.1080\/07853890.2024.2447403","article-title":"The role of cisplatin in modulating the tumor immune microenvironment and its combination therapy strategies: a new approach to enhance anti-tumor efficacy","volume":"57","author":"Li","year":"2025","journal-title":"Ann Med"},{"key":"2026052706014662800_bib45","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1186\/s13287-025-04607-9","article-title":"The PCNA inhibitor AOH1996 suppresses cancer stemness and enhances anti-PD1 immunotherapy in squamous cell carcinoma","volume":"16","author":"Wang","year":"2025","journal-title":"Stem Cell Res Ther"}],"container-title":["Cancer Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/aacrjournals.org\/cancerrescommun\/article-pdf\/doi\/10.1158\/2767-9764.CRC-25-0648\/3784068\/crc-25-0648.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerrescommun\/article-pdf\/6\/5\/1220\/3797078\/crc-25-0648.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerrescommun\/article-pdf\/6\/5\/1220\/3797078\/crc-25-0648.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T10:02:03Z","timestamp":1779876123000},"score":1,"resource":{"primary":{"URL":"https:\/\/aacrjournals.org\/cancerrescommun\/article\/6\/5\/1220\/785408\/Targeting-Cancer-Associated-PCNA-with-AOH1996"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,1]]},"references-count":45,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,5,1]]}},"URL":"https:\/\/doi.org\/10.1158\/2767-9764.crc-25-0648","relation":{"is-supplemented-by":[{"id-type":"doi","id":"10.1158\/2767-9764.32705344","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.32705356","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.32705389","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.32705368","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.32705347","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.32705362","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.32705374","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.32705341","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.32705386","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.32705359","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.32705338","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.32705380","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.32705392","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.32705383","asserted-by":"object"}],"has-preprint":[{"id-type":"doi","id":"10.1158\/2767-9764.c.8542117","asserted-by":"object"}]},"ISSN":["2767-9764"],"issn-type":[{"value":"2767-9764","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,1]]}}}